#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Chronic inflammatory demyelinating polyradiculoneuropathy Anaplastic large cell lymphoma T- and null-cell types Osteogenesis imperfecta Fibrosarcoma Peritoneal neoplasm Gastric cancer Hodgkin's disease recurrent Metastases to peritoneum Primary immunodeficiency syndrome Arteriosclerosis Neuroendocrine tumour of the lung Uveal melanoma Thrombotic microangiopathy Lymphangioma More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Life with Disease VEXAS syndrome – Life with Disease Urea cycle disorder – Diagnostics Congenital generalised lipodystrophy – Trials in Disease Niemann-Pick disease – Life with Disease SAPHO syndrome – Basic Information Myelodysplastic syndrome with excess blasts – Basic Information Encephalitis autoimmune – Trials in Disease Bronchopulmonary dysplasia – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-1167 Acasunlimab Acp-017 Bendamustine Ziprasidone Rbd1016 OMEGA-3-ACID ETHYL ESTERS 90 Censavudine Sulodexide Anhydrous Docetaxel Mk-0482 Gallium Citrate Ga-68 Tozorakimab [11C]Az14193391 Enalapril Maleate Rosuvastatin Zinc SODIUM TETRACHLOROPALLADATE TAGRAXOFUSP Asciminib Caffeine More therapies…

    Learn about Your Condition

    Angiosarcoma non-metastatic Injury Hypersomnia Pancreatic carcinoma stage IV Chronic myeloid leukaemia Tissue anoxia Acute myocardial infarction Keratosis follicular Herpes zoster Femoral hernia Arterial stiffness Cardiac failure congestive Neurotrophic keratopathy Pharyngeal cancer stage II Dedifferentiated liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Plasma cell myeloma

  • Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Alnuctamab
    • Dexamethasone Dihydrogen Phosphate Disodium Ph. Eur.
    • Carfilzomib
    Austria Belgium Czechia France Germany Greece +8

  • Study of Venetoclax, Daratumumab, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Acetate
    • Bortezomib
    • Daratumumab
    Denmark France Germany

  • Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Carfilzomib
    • Dexamethasone
    Austria Belgium Czechia Denmark France Germany +7

  • Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    • Plasma cell myeloma
    Investigated Drugs:
    • Ixazomib
    • Ixazomib Citrate
    • Dexamethasone Ph. Eur.
    Belgium France Germany Italy The Netherlands Norway +1

  • Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Cevostamab
    • Tocilizumab
    Belgium France Germany Italy Spain

  • Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Ixazomib Citrate
    • Thalidomide
    • Bortezomib
    Czechia Greece Italy
Previous Page
1 … 19 20 21 22 23 … 27
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!